The rise in employee cost-sharing for healthcare predates Obamacare but has taken off since the law passed in 2010. Higher deductibles have been accompanied by stagnant wages, ensuring that the higher payments are deeply felt.
People with private health coverage have seen a sharp rise in the portion they pay out of pocket, a trend that predates the Affordable Care Act but has taken off since the law passed in 2010, according to an analysis published by the Peterson-Kaiser Health System Tracker.
Gary Claxton, Larry Levitt, MPP; and Michelle Long, MPH; writing for the Kaiser Family Foundation, found that cost-sharing for patients jumped 77% for the period from 2004 to 2014. To arrive at this figure, the authors analyzed a claims sample from the Truven MarketScan Commercial Claims and Encounter Database.
The sample included between 785,000 and 15.3 million enrollees per year and was limited to health plan enrollees with at least 6 months of coverage from large employers.
The authors note that they could not capture balance billing for services that come patients may have received from out-of-network providers—a trend that has picked up steam in the last few years as health plans have embraced “narrow networks” to contain costs.
“We find that, between 2004 and 2014, average payments for deductibles and coinsurance rose considerably faster than the overall cost for covered benefits, while the average payments for copayments fell,” they wrote.
Overall, the authors found patient cost-sharing increased from $422 to $747 for the period studied—and more recent data they mention in their report suggests deductibles in particular jumped again for 2015. For health plans, meanwhile, payments rose 58%, from $2748 to $4354.
“This reflects a modest decline in the average generosity of insurance—large employer plans covered 86.7% of covered medical expenses on average in 2004, decreasing to 85.3% in 2014,” they wrote.
The problem, they write, is that while out-of-pocket payments for healthcare rose, wages did not. They rose only 32% from 2004 to 2014. The study period spans the Great Recession, during which unemployment peaked at 10.0% in October 2009, and many Americans saw savings and investment accounts wiped out.
Those in the top 15% of healthcare spenders, who consume 74.8% of the benefit costs, had substantially higher out-of-pocket costs. These enrollees’ average out-of-pocket was $2679 in 2014, including $1249 in coinsurance, $928 for deductibles, and $502 in copayments.
Over time, deductibles have become a more prominent feature of employee cost-sharing. They accounted for 24% of the pie in 2004 but were nearly half, at 47% in 2014. The authors speculate that the trend may have been designed to make employees more conscious of the cost of healthcare services and more wise in choosing them. But critics of this system say if a deductible is unaffordable, it causes some to delay needed care, which can have consequences—and higher costs—down the road.
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More
Gene and Cell Therapies Hold Potential—but How Can Payers Manage Their Costs?
April 18th 2024Presenters at the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting discussed the current promise and future potential of gene and cell therapies, as well as payer management strategies for these costly treatments.
Read More